Taken together, the results from this study demonstrate divergent prognostic roles for EGFR and HER3 expression in gastric and esophageal adenocarcinoma, based on IHC analysis of chemo- radiotherapy-naive tumours from a clinically well-characterized, consecutive cohort of surgically treated patients. The gene discussed is EGFR; the disease is neoplasm.